Clinical trial
A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular…
NCT00454389 · NeoVista, Industry · Unknown status
Key facts
| NCT number | NCT00454389 |
|---|---|
| Title | A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration |
| Official title | A Randomized, Prospective, Active Controlled, Study of the Epi-Rad90™ Ophthalmic System for the Treatment of Subfoveal Choroidal Neovascularization Associated With Wet Age-Related Macular Degeneration |
| Acronym | CABERNET |
| Lead sponsor | NeoVista, Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Macular Degeneration |
| Intervention type | Device, Drug |
| Interventions | Epi-Rad90™ Ophthalmic System, ranibizumab |
| Enrollment | 494 |
| Start date | Apr 1, 2007 |
| Primary completion | Sep 1, 2011 |
| Completion | Aug 1, 2012 |
| First posted | Mar 30, 2007 |
| Last update posted | Jul 27, 2011 |
| Countries | Austria, Germany, Ireland, Israel, Peru, Spain, Switzerland, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: